Literature DB >> 21249592

Assessments of the reliability of the Iranian version of the Berg Balance Scale in patients with multiple sclerosis.

Akram Azad1, Ghorban Taghizadeh, Arash Khaneghini.   

Abstract

PURPOSE: Because of the balance limitations in many patients, balance assessment is necessary for multiple sclerosis patients in rehabilitation settings. The aim of this study was to investigate the Interrater reliability and the internal consistency of the Iranian version of the Berg Balance Scale (BBS) when applied to patients with multiple sclerosis (MS) in Tehran.
METHODS: Fifty MS patients (with mean age of 36.6±9.5 years) from Hospitals of the Iran University of Medical Sciences and MS Society of Iran were included. Interrater reliability was measured with the Kappa statistics and Intraclass Correlation Coefficients (ICCs).
RESULTS: The mean values of the BBS scored by the 2 evaluators were 37.7 ±12.9 and 38.l ± 12.3, respectively. Kappa scores for BBS varied from 0.7 to 1.0 Intraclass correlation coefficient for the BBS's sum score was excellent (ICC=0.99 with 95% confidence interval, 0.98-0.99). An excellent internal consistency was found within the BBS's sum score (Cronbach Alpha =0.9). The item -to -total correlations for all items were higher than 0.6.
CONCLUSION: The Iranian version of the BBS has excellent interrater reliability and internal consistency for the assessment of MS patients when applied in clinics.

Entities:  

Mesh:

Year:  2011        PMID: 21249592

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  7 in total

1.  Effect of combination exercise therapy on walking distance, postural balance, fatigue and quality of life in multiple sclerosis patients: a clinical trial study.

Authors:  Bahram Sangelaji; Seyed Massood Nabavi; Fatemeh Estebsari; Mohammad Reza Banshi; Hamideh Rashidian; Ensiyeh Jamshidi; Maryam Dastoorpour
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

2.  A combined exercise model for improving muscle strength, balance, walking distance, and motor agility in multiple sclerosis patients: A randomized clinical trial.

Authors:  Bahram Sangelaji; Mohammadreza Kordi; Farzaneh Banihashemi; Seyed Massood Nabavi; Sara Khodadadeh; Maryam Dastoorpoor
Journal:  Iran J Neurol       Date:  2016-07-06

3.  Higher Disease and Pain Severity and Fatigue and Lower Balance Skills Are Associated with Higher Prevalence of Falling among Individuals with the Inflammatory Disease of Neuromyelitis Optica Spectrum Disorder (NMOSD).

Authors:  Mahdi Barzegar; Dena Sadeghi Bahmani; Omid Mirmosayyeb; Reyhaneh Azarbayejani; Alireza Afshari-Safavi; Saeed Vaheb; Nasim Nehzat; Afshin Dana; Vahid Shaygannejad; Robert W Motl; Serge Brand
Journal:  J Clin Med       Date:  2020-11-09       Impact factor: 4.241

4.  Effect of Neuromuscular Exercises on Strength, Proprioceptive Receptors, and Balance in Females with Multiple Sclerosis.

Authors:  Maryam K Sokhangu; Nader Rahnama; Masoud Etemadifar; Mehdi Rafeii; Ali Saberi
Journal:  Int J Prev Med       Date:  2021-01-19

5.  Psychometric Properties of the Urdu Translation of Berg Balance Scale in People with Parkinson's Disease.

Authors:  Muhammad Kashif; Ashfaq Ahmad; Muhammad Ali Mohseni Bandpei; Syed Amir Gilani; Humaira Iram; Maryam Farooq
Journal:  Int J Environ Res Public Health       Date:  2022-02-18       Impact factor: 3.390

6.  Inter-rater reliability of the Berg Balance Scale, 30 s chair stand test and 6 m walking test, and construct validity of the Berg Balance Scale in nursing home residents with mild-to-moderate dementia.

Authors:  Elisabeth Wiken Telenius; Knut Engedal; Astrid Bergland
Journal:  BMJ Open       Date:  2015-09-07       Impact factor: 2.692

7.  Effect of dynamic neuromuscular stabilization on balance and trunk function in people with multiple sclerosis: protocol for a randomized control trial.

Authors:  Laleh Abadi Marand; Shohreh Noorizadeh Dehkordi; Mahtab Roohi-Azizi; Mehdi Dadgoo
Journal:  Trials       Date:  2022-01-21       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.